A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION
Authors:
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 53 (5) , 349-352
Abstract
HIV-infected patients presenting with oral or oesophageal candidosis were randomised to four weeks treatment with itraconazole 200 mg, followed by itraconazole or matching placebo for a prophylaxis phase of 24 weeks. Clinical and mycological evidence of candidosis infection was assessed on a four-weekly basis. Seventy patients were enrolled, of whom 50 completed 28 days of itraconazole therapy; 74% (37 patients) were clinically cured and 40% were also mycologically cured. Fifteen patients were withdrawn for a variety of reasons including non-compliance, adverse events and the use of excluded medications. Forty-four patients were enrolled in the prophylactic phase. There were significantly more relapses of candidosis, and time to candidosis was significantly shorter in the placebo group than in the itraconazole treated group (p = 0.0001). Itraconazole 200 mg daily is effective and well tolerated for the treatment and prevention of oral and oesophageal candidosis in HIV-infected patients.Keywords
This publication has 7 references indexed in Scilit:
- Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patientsreceiving long-term continuous versus intermitent fluconazole therapyAIDS, 1996
- Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patientsAIDS, 1995
- The changing spectrum of AIDS index diseases in CanadaAIDS, 1994
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIVAIDS, 1991
- Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: A double-blind placebo-controlled studyJournal of Infection, 1990
- Pharmacokinetics of itraconazole following oral administration to normal volunteersAntimicrobial Agents and Chemotherapy, 1988